Rani Therapeutics share price today

(RANI)

Rani Therapeutics share price is $1.42 & ₹120.98 as on 25 Dec 2024, 2.30 'hrs' IST

$1.42

Market is closed - opens 8 PM, 26 Dec 2024

View live Rani Therapeutics share price in Dollar and Rupees. Guide to invest in Rani Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Rani Therapeutics. Get details on the Indian mutual funds that are investing in Rani Therapeutics. Get Analyst recommendations and forecasts along with all the Rani Therapeutics's financials.

Rani Therapeutics share price movements

Today's Low: $1.37
Today's High: $1.44
$1.42
3.87%
Downside
Day's Volatility :5.21%
Upside
1.39%
52 Weeks Low: $1.30
52 Weeks High: $8.75
$1.42
8.45%
Downside
52 Weeks Volatility :85.14%
Upside
83.77%

Rani Therapeutics Returns

Period	Rani Therapeutics Holdings Inc	Index (Russel 2000)
3 Months	-32.7%	0.0%
6 Months	-63.96%	0.0%
1 Year	-57.86%	0.0%
3 Years	-93.14%	-21.1%

Rani Therapeutics Key Statistics

in dollars & INR

Previous Close	$1.42
Open	$1.4
Today's High	$1.44
Today's Low	$1.365
Market Capitalization	$83.1M
Today's Volume	$223.6K
52 Week High	$8.75
52 Week Low	$1.3
Revenue TTM	$0.0
EBITDA	$-56.9M
Earnings Per Share (EPS)	$-1.05
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-225.35%

How to invest in Rani Therapeutics from India?

It is very easy for Indian residents to invest directly in Rani Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rani Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rani Therapeutics or RANI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rani Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rani Therapeutics shares which would translate to 0.600 fractional shares of Rani Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rani Therapeutics, in just a few clicks!

Returns in Rani Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Rani Therapeutics investment value today

Current value as on today

₹44,375

Returns

₹55,625

(-55.62%)

Returns from Rani Therapeutics Stock

₹57,864 (-57.86%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Rani Therapeutics

-5%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Rani Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -5% less investors are searching Rani Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Rani Therapeutics

Armistice Capital, LLC
7.73%
Vanguard Group Inc
2.13%
Alphabet Inc
1.35%
United Services Automobile Association
0.91%
Stifel Financial Corp
0.81%
Geode Capital Management, LLC
0.52%

Analyst Recommendation on Rani Therapeutics

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Rani Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Rani Therapeutics

What analysts predicted

Upside of 709.86%

Current:

$1.42

Target:

$11.50

Insights on Rani Therapeutics

Price Movement
In the last 7 days, RANI stock has moved up by 9.2%
RANI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 84.2%
RANI vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 117.6%

Rani Therapeutics Technicals Summary

Sell

Neutral

Buy

Rani Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Rani Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rani Therapeutics Holdings Inc	-27.18%	-63.96%	-57.86%	-93.14%	-87.09%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rani Therapeutics Holdings Inc	NA	NA	NA	-1.01	-2.25	-0.57	NA	0.49
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rani Therapeutics Holdings Inc	Buy	$83.1M	-87.09%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Rani Therapeutics

Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs.

Organization	Rani Therapeutics
Employees	140
CEO	Mr. Mir A. Imran
Industry	Miscellaneous

Management People of Rani Therapeutics

Name	Title
Mr. Mir A. Imran	Executive Chairman
Mr. Talat Imran	CEO & Director
Mr. Svai S. Sanford	Chief Financial Officer
Dr. Mir Hashim	Chief Scientific Officer
Mr. Alireza Javadi	Vice President of Technical Operations
Ms. Bella Vazquez	Vice President of Human Resources
Ms. Kate McKinley M.B.A.	Chief Business Officer
Ms. Arvinder Dhalla	Vice President of Clinical Development

Important FAQs about investing in Rani Therapeutics from India :

What is Rani Therapeutics share price today?

Rani Therapeutics share price today stands at $1.42, Open: $1.40 ; Previous Close: $1.42 ; High: $1.44 ; Low: $1.37 ; 52 Week High: $8.75 ; 52 Week Low: $1.30. The stock opens at $1.40, after a previous close of $1.42. The stock reached a daily high of $1.44 and a low of $1.37, with a 52-week high of $8.75 and a 52-week low of $1.30.

Can Indians buy Rani Therapeutics shares?

Yes, Indians can invest in the Rani Therapeutics (RANI) from India.

With INDmoney, you can buy Rani Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rani Therapeutics at zero transaction cost.

How can I buy Rani Therapeutics shares from India?

It is very easy to buy Rani Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rani Therapeutics be purchased?

Yes, you can buy fractional shares of Rani Therapeutics with INDmoney app.

What are the documents required to start investing in Rani Therapeutics stocks?

To start investing in Rani Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.